Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Using steroids can increase the risk of heart problems.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

Hair loss in women linked to higher sexual dysfunction risk.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Dianabol boosts muscle growth but has serious health risks and legal issues.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS and suggest the need for further tests for related health issues.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.